Product Development Program. 4.1 Section 4.1 of the Agreement is hereby amended and restated in its entirety as follows:
Product Development Program. The term “
Product Development Program. 2.1 Promptly after execution of this Agreement and approval of a work plan as described in Section 2.2, ALZA will commence the Program activities necessary to continue development of the New Models. In connection with the Program, both parties will make available appropriate scientific, engineering and other *Material has been omitted pursuant to a request for confidential treatment, and such material has been filed separately with the SEC. 10 personnel to perform tasks under the Program. The parties will use reasonable commercial efforts to carry out the Program, will participate in periodic conferences to review its status and will cooperate in the prompt preparation and review of, and discussion concerning, work plans and cost estimates and revisions thereto described in Section 2.2.
Product Development Program. After the Effective Date, Zai Lab will, either by itself or through its Affiliates, licensees and/or sublicensees, be solely responsible for designing and performing all aspects of the Development Program in accordance with the Development Plan, provided that Zai Lab may undertake changes to its development plans from time to time as long as it continues to satisfy its diligence obligations under this Agreement. Zai Lab will have sole responsibility and control for the managing and the financing of the Development Plan and all Development Costs. The primary focus of the Development Program will be to Develop and obtain Regulatory Approvals for one or more Products.
Product Development Program. The fourth sentence of Section 2.3(b) and Section 2.6 in its entirety of the Original Agreement are hereby deleted.
Product Development Program. 2.1 Promptly after execution of this Agreement and receipt from BioMedicines of Drug and the materials described in Section 2.3, the parties will commence the [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES EXCHANGE ACT OF 1933, AS AMENDED.
Product Development Program. 2.1 Subject to the terms of this Agreement, Kodak hereby agrees to diligently undertake the Development Program for Medis according to the Statements of Work, using Eastman Kodak Company standards of engineering and technical xxxxxxxnce to conduct the development work. Medis hereby authorizes Kodak to proceed with tasks of the agreed to Statements of Work as provided in Article 2.2
Product Development Program. Product Development Program shall mean the Initial Product Development Program and any Additional Product Development Program(s).
Product Development Program. 2.1 Product Candidate Identification Process. Within 30 days ---------------------------------------- after the date of the Distribution and at least annually thereafter, ALZA shall provide Crescendo with a proposed Work Plan covering activities to be undertaken by ALZA to search for and identify Product Candidates for consideration by Crescendo under Section 2.2 and to identify potential Technical Evaluations for consideration by Crescendo under Section 2.4. Promptly after ALZA provides Crescendo with such proposed Work Plan, Crescendo shall notify ALZA of its acceptance or rejection of such proposed Work Plan.
Product Development Program. 2.1 Upon execution of this Agreement, VAXCEL and CLI shall commence the Program pursuant to the initial Work Plan attached hereto as Exhibit A. CLI shall ensure that any Product feasibility evaluation and/or development shall be performed in accordance with U.S. Food and Drug Administration and cGLP regulations. Within thirty (30) days following completion of pre-clinical studies, CLI shall provide VAXCEL with a written report of the results, and such report and the data shall be deemed Program Information and shall be jointly owned by CLI and VAXCEL in accordance with Section 3.1. After completion of the feasibility work contemplated by the initial Work Plan, VAXCEL and CLI agree to cooperate in devising mutually agreeable Work Plans and cost estimates for further development of the Product; such Work Plans may include but are not limited to times for mutual reporting of results and times when crucial decisions are to be made. Each party agrees to use its reasonable efforts to review, execute and proceed diligently under the agreed-upon initial Work Plan and any additional or amended agreed-upon Work Plans and to report significant deviations therefrom, in a timely fashion. Each party agrees to revise such Work Plans from time to time so that the Work Plans may remain a good faith estimate of the work to be done and of Development Costs. The parties shall participate in periodic conferences to review the current Work Plan and the status of the Program. These conferences will be held on an "as needed" basis in the spirit of collaboration, but at least every sixty (60) days. Notwithstanding the foregoing, (i) all Work Plans, cost estimates and any major deviations therefrom shall be submitted in writing by the responsible party for the other party's approval and (ii) neither party shall be required to perform any work which would result in Development Costs exceeding approved cost estimates.
